Volume 5, Issue 13: Anti-pseudomonal agents for the management of P. aeruginosa infection

e-Cystic Fibrosis Review is a monthly CE series for nurses, nurse practitioners, and others involved in the care of patients with Cystic Fibrosis. It provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.

(Volume 5, Issue 13)


Target Audience

Nurses and health care professionals involved in the care of patients with Cystic Fibrosis.

Learning Objectives

After participating in this activity, the participant will demonstrate the ability to: 

  • Describe recent clinical trials of inhaled antibiotics for treatment of chronic 
  • Summarize new findings describing P. aeruginosa airway dynamics and biofilm antibiotics susceptibility testing in acute CF pulmonary exacerbations P. aeruginosa infection. 
  • Discuss the impact of treatment with CFTR correctors/potentiators on chronic P. aeruginosa infection.


Additional information
Contact email: 
Course summary
Available credit: 
  • 1.00 ANCC
  • 1.00 Attendance
Registration opens: 
Registration closes: 
Shawn Aaron, MD
Senior Scientist, Clinical Epidemiology Program
Ottawa Hospital Research Institute
Division Director- Respirology
University of Ottawa
Ottawa, Ontario CA


Dr. Shawn Aaron reports he has no relevant relationships with a commercial entity.


Unlabeled/Unapproved Uses

Dr. Shawn Aaron reports there will be no discussions of off-label or unapproved uses of drugs or products.


Available Credit

  • 1.00 ANCC
  • 1.00 Attendance


Please login or register to take this course.

Required Hardware/software

Make sure your Adobe flash is updated by clicking HERE